Poland· PL-100134246

Risperon

A risperidone product containing risperidonum, registered in Poland by Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC N05AX08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRisperonATCN05AX08REGISTER NO.PL-100134246PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Risperidone is registered in 19 of 19 countries.

Countries holding a registration under ATC N05AX08 (risperidone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Risperidone · ATC N05AX08

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risperidone costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.52 in Czechia to $3.93 in Switzerland — a ×7.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Risperidone · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.93
  • IT Italy$1.34
  • FR France$0.77
  • CZ Czechia$0.52
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Risperidonum
Manufacturer
Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
Country
Poland (PL)
ATC code
N05AX08
ATC class
Risperidone
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

2 priced
  • gtin
    05909991126711
  • gtin
    05909991126728
  • gtin
    05909991126735
  • gtin
    05909990336586
    20 szt.
    PLN 36.19
  • gtin
    05909990336609
    60 szt.
    PLN 100.24
  • gtin
    05909991126742
  • gtin
    05909990336593

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

542 interactions on record for risperidone.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Risperidone · interactions on record

542 records

  • 45 severe
  • 286 moderate
  • 4 minor
  • 136 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PasireotideH01CB05severe

71 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Risperidone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All risperidone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Risperdal, Risperdal Consta
  • Belgium · Risperdal, Risperdal Consta
  • Bulgaria · Медориспер, Рисар
  • Cyprus · Eperon, Risperdal
  • Czechia · Medorisper, Rileptid
  • Germany · Risperdal, Risperdal Consta
  • Denmark · Rispemyl, Risperanne
  • Estonia · Medorisper, Risperidon Actavis
  • Spain · Arketin, Risperdal
  • Finland · Rismyl, Risperdal
  • France · Risperdal, Risperdalconsta L.P.
  • United Kingdom (Northern Ireland) · Risperdal Consta, Risperidione Wockhardt Uk Ltd
  • Greece · Adovia, Axelabron
  • Croatia · Prospera, Risdonal
  • Hungary · Perdox, Rileptid
  • Ireland · Perdamel, Risperdal
  • Iceland · Okedi, Ríson
  • Italy · Risperdal, Risperidone Aurobindo
  • Liechtenstein · Okedi, Risperdal Consta
  • Lithuania · Medorisper, Risperidon Actavis
  • Luxembourg · Risperdal, Risperdal Consta
  • Latvia · Medorisper, Rispaxol
  • Malta · Eperon, Evitrat
  • Netherlands · Risperdal, Risperdal Consta
  • Norway · Okedi, Risperdal
  • Portugal · Risperdal, Risperdal Consta
  • Romania · Rispen, Risperidonă Arena
  • Sweden · Medorisper, Rispemyl
  • Slovenia · Risperdal, Risperdal Consta
  • Slovakia · Medorisper, Rispen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f532b9ef-56d2-45a8-b4ac-72748d1a6260
GET /v1/drugs/f532b9ef-56d2-45a8-b4ac-72748d1a6260?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "4 mg",
  "packaging": "05909991126711 ¦ Rp ¦ Skasowane ¦ 26368\n10 tabl. w blistrze\n05909991126728 ¦ Rp ¦ Skasowane ¦ 26369\n20 tabl. w pojemniku\n05909991126735 ¦ Rp ¦ Skasowane ¦ 26370\n40 tabl. w pojemniku\n05909991126742 ¦ Rp ¦ Skasowane ¦ 26371\n60 tabl. w pojemniku\n05909990336586 ¦ Rp ¦ 31998\n20 tabl.\n05909990336593 ¦ Rp ¦ Skasowane ¦ 31999\n40 tabl.\n05909990336609 ¦ Rp ¦ 32000\n60 tabl.",
  "substance": "Risperidonum 4 mg",
  "common_name": "Risperidonum",
  "pl_product_id": "100134246",
  "pozwolenie_nr": "11267",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about risperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.